Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Myasthenia Gravis and Coronavirus Disease 2019: A Report From Iran Publisher



Etemadifar M1 ; Akafzadehsavari M2 ; Salari M3 ; Akhavan Sigari A2 ; Ebrahimipelarti S2 ; Sedaghat N2 ; Etemad K4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurosurgery, Al-Zahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Al-Zahra Research Institute, Al-Zahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical sciences, Tehran, Iran

Source: Current Journal of Neurology Published:2021


Abstract

Background: Coronavirus disease 2019 (COVID-19) is spreading rapidly and has affected millions of people worldwide. Comorbid diseases have complicated the course of infection and increased mortality. Myasthenia gravis (MG) affects the neuromuscular junctions (NMJs) and can compromise respiratory muscle action, leading to worse clinical outcomes in individuals infected with the COVID-19 theoretically. In this study, the aim is to assess the pattern of COVID-19 infection in patients with MG based on several factors. Methods: This was a prospective cohort study following 150 patients with MG over a six-month period. The patients were monitored for the development of signs and symptoms of the COVID-19 infection. Results: Comparison of the patients infected with COVID-19 with MG and those not infected was performed independently based on age, duration since MG diagnosis, status of thymectomy, and current clinical status of MG disease. Data analysis did not reveal increased susceptibility or increased severity of COVID-19 illness based the criteria assessed. Conclusion: COVID-19 related deaths and susceptibility were not related to age, thymectomy status, and disease duration in patients with MG. © 2021 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Myasthenia Gravis and Covid-19: A Systematic Review and Meta-Analysis, Basic and Clinical Neuroscience (2024)
2. Is Myasthenia Gravis a Real Complication of the Covid-19 Vaccine? a Case Report-Based Systematic Review, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
3. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
4. Clinical Symptoms of Covid-19 and Their Association With Disease Outcome, Advanced Biomedical Research (2022)
5. Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial, International Immunopharmacology (2020)
6. Epidemiological Review of the Coronavirus Disease 2019 (Covid-19) Pandemic up to 15 March 2020, Journal of Isfahan Medical School (2020)
7. Clinical, Laboratory and Imaging Characteristics, and Outcomes of Hospitalized Children With Suspected Covid-19 Infection: A Report From Isfahan-Iran, Journal of Research in Medical Sciences (2022)
8. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
Experts (# of related papers)
View all Related Experts
Ramin Sami (12)
Marjan Mansourian (10)
Other Related Docs
9. Artificial Neural Network and Logistic Regression Modelling to Characterize Covid-19 Infected Patients in Local Areas of Iran, Biomedical Journal (2021)
10. Rhabdomyolysis Secondary to Covid-19 Infection and Vaccination: A Review of Literature, Frontiers in Medicine (2024)
11. Cardiac Involvement According to Echocardiographic Findings in Severe Coronavirus Disease 2019, ARYA Atherosclerosis (2021)
12. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
13. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
14. Association of Systemic Complications With Mortality in Coronavirus Disease of 2019: A Cohort Study on Intensive Care Unit Patients, Journal of Research in Medical Sciences (2022)
15. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
16. Neuro-Mucormycosis: Lessons From Covid-19-Associated Cases, Current Journal of Neurology (2023)
17. Rehabilitation, a Necessity in Hospitalized and Discharged People Infected With Covid-19: A Narrative Review, Physical Therapy Reviews (2021)
18. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
19. Controlling and Prevention of Novel Coronavirus Through Health and Safety Protocols in Food: Review Article, Tehran University Medical Journal (2021)
20. Potential Factors Related to Post-Covid-19 Persistent Symptoms; Khorshid Covid Cohort Study, Immunopathologia Persa (2023)
21. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
22. Cerebellitis Following Covid-19 Infection: A Case-Based Systematic Review and Pooled Analysis, Heliyon (2024)
23. Guillain-Barre Syndrome and Covid-19 Vaccine: A Report of Nine Patients, Basic and Clinical Neuroscience (2021)
24. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
25. Risk Factors of Covid-19 Associated Mucormycosis in Iranian Patients: A Multicenter Study, BMC Infectious Diseases (2024)
26. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
27. A Systematic Review of the Histopathologic Survey on Skin Biopsies in Patients With Corona Virus Disease 2019 (Covid-19) Who Developed Virus or Drug-Related Mucocutaneous Manifestations, Experimental Dermatology (2021)
28. Acute Otitis Media and Covid-19 Symptoms: A Case Report, Auditory and Vestibular Research (2021)
29. Neuropsychiatric Manifestations of Covid-19 in Hospitalized Pediatrics: A Multicenter Cross-Sectional Study, Archives of Pediatric Infectious Diseases (2023)
30. Differential Diagnostic Utility of Clinical Laboratory Data in Patients With Severe and Non-Severe Covid-19, Shiraz E Medical Journal (2022)
31. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
32. Acute Necrotizing Encephalopathy in Adult Patients With Covid-19: A Systematic Review of Case Reports and Case Series, Journal of Clinical Neurology (Korea) (2023)
33. Skin Manifestations As Potential Symptoms of Diffuse Vascular Injury in Critical Covid-19 Patients, Journal of Cutaneous Pathology (2021)
34. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
35. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
36. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
37. Rhabdomyolysis Plus Hypocalcemia and Diabetic Ketoacidosis As Concurrent Rare Covid-19 Manifestations, Case Reports in Medicine (2021)
38. Cardiovascular Complications of Covid-19 Vaccines: A Review of Case-Report and Case-Series Studies, Heart and Lung (2023)
39. Covid-19 Associated Mucormycosis Surge: A Review on Multi-Pathway Mechanisms, Parasite Immunology (2024)
40. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
41. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
42. Central Nervous System Vasculopathy Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2): A Novel Case Report From Iran, Journal of NeuroVirology (2021)
43. Hypophosphatemia in Coronavirus Disease 2019 (Covid-19), Complications, and Considerations: A Systematic Review, BioMed Research International (2022)
44. Frequency of Myasthenia Gravis in Multiple Sclerosis: Report of Five Cases From Isfahan, Iran, Neurology India (2009)
45. The Severity of Symptoms and Outcomes of Patients Admitted With Rheumatic Diseases and Covid-19; a Prospective Cohort Study in Iran, Immunopathologia Persa (2021)
46. Association Between Clinical Characteristics and Laboratory Findings With Outcome of Hospitalized Covid-19 Patients: A Report From Northeast Iran, Interdisciplinary Perspectives on Infectious Diseases (2021)
47. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
48. Chronic Kidney Disease and Covid-19 Infection: A Case–Control Study, Advanced Biomedical Research (2022)
49. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
50. Para-Cardiac Inflammatory Mass Compressing the Heart a Possible Association With Covid-19, Sultan Qaboos University Medical Journal (2023)